Suppr超能文献

在帕金森病细胞氧化模型中,α-突触核蛋白酪氨酸-39位点的硝化作用优先增强。

Preferentially increased nitration of alpha-synuclein at tyrosine-39 in a cellular oxidative model of Parkinson's disease.

作者信息

Danielson Steven R, Held Jason M, Schilling Birgit, Oo May, Gibson Bradford W, Andersen Julie K

机构信息

Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, California 94945, USA.

出版信息

Anal Chem. 2009 Sep 15;81(18):7823-8. doi: 10.1021/ac901176t.

Abstract

Alpha-synuclein is a major component of Lewy bodies, proteinacious inclusions which are a major hallmark of Parkinson's disease (PD). Lewy bodies contain high levels of nitrated tyrosine residues as determined by antibodies specific for 3-nitrotyrosine (3NT) and via mass spectrometry (MS). We have developed a multiple reaction monitoring (MRM) mass spectrometry method to sensitively quantitate the 3NT levels of specific alpha-synuclein tyrosine residues. We found a 9-fold increase (relative to controls) in levels of 3NT at Tyr-39 of alpha-synuclein in an inducible transgenic cellular model of Parkinson's disease in which monoamine oxidase B (MAO-B) is overexpressed and which emulates several features of PD. Increased nitration of Tyr-39 on endogenous alpha-synuclein via elevations in MAO-B levels could be abrogated by the addition of deprenyl, a specific MAO-B inhibitor. The increased levels of 3NT was selective for Tyr-39 as no significant increases in 3NT levels were detected at other tyrosine residues present in the protein (Tyr-125, Tyr-133, and Tyr-136). This is the first report of increased 3NT levels of a specific tyrosine in a PD model and the first use of MRM mass spectrometry to quantify changes in 3NT modifications at specific sites within a target protein.

摘要

α-突触核蛋白是路易小体的主要成分,路易小体是帕金森病(PD)的主要标志,为蛋白质包涵体。通过针对3-硝基酪氨酸(3NT)的特异性抗体以及质谱分析(MS)确定,路易小体含有高水平的硝化酪氨酸残基。我们开发了一种多反应监测(MRM)质谱方法,用于灵敏地定量特定α-突触核蛋白酪氨酸残基的3NT水平。在一种帕金森病的诱导性转基因细胞模型中,我们发现α-突触核蛋白第39位酪氨酸残基的3NT水平相对于对照增加了9倍,该模型中过表达单胺氧化酶B(MAO-B),模拟了帕金森病的若干特征。通过添加特异性MAO-B抑制剂司来吉兰,可以消除因MAO-B水平升高导致的内源性α-突触核蛋白第39位酪氨酸硝化增加。3NT水平的增加对第39位酪氨酸具有选择性,因为在该蛋白的其他酪氨酸残基(第125位、第133位和第136位酪氨酸)处未检测到3NT水平有显著增加。这是关于帕金森病模型中特定酪氨酸的3NT水平升高的首次报道,也是首次使用MRM质谱法定量目标蛋白特定位点3NT修饰变化的报道。

相似文献

6
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.
J Proteome Res. 2019 May 3;18(5):2109-2120. doi: 10.1021/acs.jproteome.8b00982. Epub 2019 Apr 15.
9
Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies.
J Neurochem. 2004 Feb;88(4):800-12. doi: 10.1046/j.1471-4159.2003.02168.x.

引用本文的文献

1
Differential role of C-terminal truncations on alpha-synuclein pathology and Lewy body formation.
NPJ Parkinsons Dis. 2025 Aug 26;11(1):261. doi: 10.1038/s41531-025-01084-y.
3
The Role of α-Synuclein in Etiology of Neurodegenerative Diseases.
Int J Mol Sci. 2024 Aug 24;25(17):9197. doi: 10.3390/ijms25179197.
4
A Versatile Method for Site-Specific Chemical Installation of Aromatic Posttranslational Modification Analogs into Proteins.
J Am Chem Soc. 2024 Sep 18;146(37):25788-25798. doi: 10.1021/jacs.4c08416. Epub 2024 Sep 3.
6
α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil.
Neural Regen Res. 2024 Jul 1;19(7):1463-1472. doi: 10.4103/1673-5374.387967. Epub 2023 Nov 8.
7
Alpha synuclein post translational modifications: potential targets for Parkinson's disease therapy?
Front Mol Neurosci. 2023 May 25;16:1197853. doi: 10.3389/fnmol.2023.1197853. eCollection 2023.
10
Nitrosative stress in Parkinson's disease.
NPJ Parkinsons Dis. 2022 Aug 11;8(1):104. doi: 10.1038/s41531-022-00370-3.

本文引用的文献

2
Alpha-Synuclein conformation affects its tyrosine-dependent oxidative aggregation.
Biochemistry. 2008 Dec 23;47(51):13604-9. doi: 10.1021/bi801884z.
3
Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites.
Mol Cell Proteomics. 2009 Mar;8(3):467-80. doi: 10.1074/mcp.M800282-MCP200. Epub 2008 Nov 3.
4
Akt activates NOS3 and separately restores barrier integrity in H2O2-stressed human cardiac microvascular endothelium.
Am J Physiol Heart Circ Physiol. 2008 Dec;295(6):H2417-26. doi: 10.1152/ajpheart.00501.2008. Epub 2008 Oct 17.
5
Alpha-synuclein misfolding and neurodegenerative diseases.
Curr Protein Pept Sci. 2008 Oct;9(5):507-40. doi: 10.2174/138920308785915218.
6
Factors that contribute to the misidentification of tyrosine nitration by shotgun proteomics.
Mol Cell Proteomics. 2008 Dec;7(12):2442-51. doi: 10.1074/mcp.M800065-MCP200. Epub 2008 Aug 16.
7
Compromised proteasome degradation elevates neuronal nitric oxide synthase levels and induces apoptotic cell death.
Arch Biochem Biophys. 2008 Oct 15;478(2):181-6. doi: 10.1016/j.abb.2008.07.022. Epub 2008 Aug 5.
8
Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.
J Neurochem. 2007 Oct;103(1):17-37. doi: 10.1111/j.1471-4159.2007.04764.x. Epub 2007 Jul 10.
9
Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks.
Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5860-5. doi: 10.1073/pnas.0608638104. Epub 2007 Mar 26.
10
Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.
J Biol Chem. 2006 Oct 6;281(40):29739-52. doi: 10.1074/jbc.M600933200. Epub 2006 Jul 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验